Incontinence and Ostomy Care Products Market is segmented By Product Type (Incontinence Care Products, Ostomy Care Products), By Applications (Oncology, Women Health Related, GI Tract Diseases, Neurological Conditions, Urinogenital Diseases), By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030
Market Overview
[180 Pages Report] The Incontinence and Ostomy Care Products Market is expected to grow at a high CAGR during the forecasting period (2023-2030). Urinary incontinence is a condition in which bladder control is lost. It is a common problem where the severity ranges from occasionally leaking urine when you cough or sneeze to having an urge to urinate that's so sudden and strong that an individual cannot control it. An ostomy is a surgery to create an opening (stoma) from an area inside the body to the outside. This procedure is done to treat certain diseases of the digestive or urinary systems. It can be used permanent or temporary when an organ is removed forever or an organ requires time to heal, respective
Report Scope
|
Metrics |
Details |
|
Market CAGR |
High |
|
Segments Covered |
By Product Type, By Applications and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
Market Dynamics and Trends
The factors driving the growth of this market are the growing prevalence of urologic disorders such as urinary retention, urinary incontinence and kidney stones, which leads to bladder dysfunction. Additionally, the increasing geriatric population is the key factor that will drive the Incontinence and Ostomy Care Products Market growth.
The growing prevalence of urologic disorders will drive the market growth
Urologic illnesses, problems, and conditions influence individuals, bring about huge medical problems, and prompt significant incapacity. Non-carcinogenic (benign) urologic medical conditions incorporate urinary tract contaminations, kidney stones, urinary incontinence. Bladder pain is a difficult condition, is expected to occur in 3.3 million ladies. Based upon national public health surveys conducted over several years, it is assessed that 1 of every 10 U.S. grown-ups (18 years old and more seasoned) experience the ill effects of everyday urinary incontinence; a large portion of those influenced are ladies. Many suffer in silence because of humiliation and the absence of information about accessible treatment alternatives. Due to the expanded danger of colorectal and urinary bladder malignancy, there is a more prominent interest in ostomy care items.
The increasing geriatric population is driving the market growth
Urinary incontinence, the involuntary loss of urine, has a very high prevalence rate in people above 60 years. The most common types of urinary incontinence seen in older people are stress incontinence and urge incontinence. Urge incontinence happens when people suddenly need to urinate and cannot hold their urine long enough to get to the toilet. It may be a problem for people with diabetes, Alzheimer's disease, Parkinson's disease, multiple sclerosis, or stroke.
According to WHO, the prevalence of urinary incontinence reported in population-based studies ranges from 9.9% to 36.1% (2–4) and is twice as high in older women as in older men.
Complications associated with Ostomy and usage of incontinence products will hamper the market
Ostomies can be permanent or temporary. Most complications associated with stomas are minor, but some, especially necrosis and dehydration, can turn into medical emergencies. Intestinal stomas undoubtedly will dramatically change lifestyles. Patients will experience physiologic and psychologic detriment with stoma-related problems.
The majority of people wearing incontinence products, or adult diapers, are wearing the wrong products leading to illness, discomfort, and loss of dignity. According to the World Health Organization (WHO), more than 200 million people worldwide experience incontinence, and there are limited resources available to help them manage their condition and lack of awareness. If patients decide to seek help at all: 70% of people with incontinence don't seek help for their problem.
Most people with the problem are not wearing the right product, a mistake that can lead to serious health issues down the line.
According to Finnegan Medical Supply, a study found that 39% of participants wore at least one incorrect incontinence product during 24 hours. The NAFC estimates an even higher number, citing that up to 80% of adults with incontinence are wearing the wrong products
COVID-19 Impact Analysis on Incontinence and Ostomy Care Products Market
The COVID-19 pandemic has impacted the healthcare systems globally and also has a notable impact on the market. The COVID-19 pandemic has impacted the ostomy care business, as most of the acute ostomy surgeries have been performed because of the outbreak. Patients with acute and chronic diseases had to be treated at home or outpatient clinics. This increased the demand for incontinence and ostomy care products used in homecare settings.
Segmentation Analysis
The adsorbents segment dominated the market for incontinence
The high usage rates and the rise in popularity of adult diapers, as well as the increasing geriatric population. The introduction of innovative and personalized products with the aim of user-friendliness and comfort and the acceptance of products such as adult diapers. These products may absorb 20-300 mL, depending on the brand and the absorbent material of the product. Absorbent products used include underpads, panty shields, pant guards, adult diapers (briefs), various washable pants and disposable pad systems, or combinations of these products. Abena Abri-Form Premium Incontinence Briefs Level 4 Absorbency. These are a great option for adults who suffer from serious bladder problems and leaks because they are four times as absorbent as other competitor diapers in stores. These are some of the factors for the segment's growth over the forecast period.
Ostomy bags dominated the ostomy care products segment of the market
The rise in the population of patients undergoing ostomy surgeries (either ileostomy, colostomy), technological advancements in this segment, and efficient developed systems in developed countries. And the high prevalence of diseases such as Crohn's disease, colorectal cancer, Inflammatory Bowel Disease (IBD), a high number of colon surgeries, and rising patient awareness. Also, the introduction of user-friendly and skin-friendly ostomy bags may drive the market growth for incontinence and ostomy care products. An ostomy bag is a small waterproof pouch used to collect waste from the body during a surgical procedure known as a colostomy. The main distinction between the different options for ostomy bags, after determining which type you will need, is whether or not it is a one-piece or two-piece variation. One-piece ostomy bags include a skin barrier and a pouch, while two-piece ostomy bags keep the skin barrier and pouch separate. Once you determine whether or not you’ll want a one-piece or a two-piece ostomy bag, you can look at other options. According to Cancer treatment and survivorship statistics, 2016 data, colostomies requiring an ostomy bag are common in patients with colorectal cancer, which as of 2016 was the second most commonly diagnosed cancer in men and the third most commonly diagnosed cancer in women in the United States. In 2016, the number of newly diagnosed cases of colorectal cancer was 724,690 and 727,350 in men and women, respectively. Estimates suggest that there will be 910,190 newly diagnosed cases of colorectal cancer in men and 885,940 new cases in women in 2026. It has been reported that colostomy surgery is more common in patients with rectal cancer (29%) than in patients with colon cancer (12%).
The oncology segment is the fastest-growing segment
Colorectal cancer has one of the highest incidence and prevalence rates of all cancers worldwide. Colorectal cancer is a type of cancer that starts in the colon (large intestine) or rectum. Both of these organs are in the lower portion of your digestive system, and the rectum is at the end of the colon. According to cancer statistics from National Cancer Institute, Prostate, lung, and colorectal cancers account for an estimated 43% of all cancers diagnosed in men in 2020. For women, the three most common cancers are breast, lung, and colorectal, and they will account for an estimated 50% of all new cancer diagnoses in women in 2020. Approximately 39.5% of men and women will be diagnosed with cancer at some point during their lifetimes (based on 2015–2017 data).
According to The American Cancer Society (ACS), about 1 in 23 men and 1 in 25 women will develop colorectal cancer during their lifetime.
Geographical Shares
North America Dominates the market
Incontinence is a prevalent condition, with a significant proportion of the population suffering from Crohn's Disease.
According to the National Association For Incontinence, 25 million adult Americans suffer from some form of urinary incontinence, 75-80% of those in women. Urinary Incontinence affects 200 million people worldwide.
The United Ostomy Association estimates that slightly more than 500,000 Americans now have some type of stoma.
According to the Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute, approximately 100,000 people in the United States undergo operations that result in a colostomy or ileostomy each year. The high incidence of ostomy surgeries in the United States is due to the increasing prevalence of colorectal cancer and diverticular disease.
Companies and Competitive Landscape
The incontinence and ostomy care products market is moderately competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include B. Braun, Coloplast AG, ConvaTec Group plc, Hollister Incorporated, Kimberly-Clark Corporation, Medtronic plc, Salts Healthcare, Unicharm Corporation, Hebei Jinjie Health Technology Co., Ltd., Liaoning Huiyingbanzhou Medical Material Co., Ltd., Ltd. and Guangdong Carelder Health Industry Technology Co., Ltd.
Incontinence and Ostomy Care Products Market Key Companies to Watch
B. Braun
Overview: B. Braun is a German medical and pharmaceutical device company with more than 63,000 employees globally, offices and production facilities in more than 60 countries. Its headquarters are located in Melsungen, in central Germany. Every service that B. Braun provides consists of knowledge and skills, the company's deep understanding of users' needs, and more than 180 years of extensive expertise. With its constantly growing portfolio of adequate medical care solutions, B. Braun contributes towards protecting and improving people's health. The B. Braun product range comprises 5,000 different products, 95 per cent of which are manufactured by the company. B. Braun is a system supplier, which develops the best solutions by contributing to medical advancements.
Product Portfolio: The Company offers effective medical care solutions, offers product systems for anesthesia, intensive care, cardiology, extracorporeal blood treatment and surgery.
Key Development: B. Braun Interventional Systems Inc. (BIS) announced that they would collaborate with Infraredx, a Nipro company, to accelerate the U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) clinical trial for the B. Braun SeQuent® Please ReX™ Drug-Coated PTCA Balloon Catheter, which received FDA Breakthrough Device Designation in late 2019. This announcement furthers the long-term global cooperation between the B. Braun Group of Companies and Japan-based Nipro Corporation to advance coronary artery disease management.
